These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23071711)

  • 1. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil.
    Teixeira JJ; Crozatti MT; dos Santos CA; Romano-Lieber NS
    PLoS One; 2012; 7(10):e47062. PubMed ID: 23071711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the brazilian primary public health system.
    Obreli Neto PR; Nobili A; Marusic S; Pilger D; Guidoni CM; Baldoni Ade O; Cruciol-Souza JM; Da Cruz AN; Gaeti WP; Cuman RK
    J Pharm Pharm Sci; 2012; 15(2):344-54. PubMed ID: 22579012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.
    Chatsisvili A; Sapounidis I; Pavlidou G; Zoumpouridou E; Karakousis VA; Spanakis M; Teperikidis L; Niopas I
    Pharm World Sci; 2010 Apr; 32(2):187-93. PubMed ID: 20077137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol.
    van Heerden JA; Burger JR; Gerber JJ; Vlahović-Palčevski V
    Int J Pharm Pract; 2018 Apr; 26(2):156-164. PubMed ID: 28665037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C; Prado N; Acurcio F
    Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a wireless handheld medication management device in the prevention of drug-drug interactions in a Medicaid population.
    Malone DC; Saverno KR
    J Manag Care Pharm; 2012; 18(1):33-45. PubMed ID: 22235953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
    Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically important drug-drug interactions in primary care.
    Dhabali AA; Awang R; Zyoud SH
    J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of potential drug-drug interactions in bone marrow transplant patients.
    Guastaldi RB; Reis AM; Figueras A; Secoli SR
    Int J Clin Pharm; 2011 Dec; 33(6):1002-9. PubMed ID: 21993569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated factors of drug-drug interactions in elderly outpatients in a tertiary care hospital: a cross-sectional study based on three databases.
    Liu Y; Wang J; Gong H; Li C; Wu J; Xia T; Li C; Li S; Chen M
    Ann Transl Med; 2023 Jan; 11(1):17. PubMed ID: 36760261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
    Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
    J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
    Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
    Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug-drug interactions with psychotropic drugs in paediatric inpatients: A cross-sectional study.
    Yalçın N; Özdemir N; Çak Esen HT; Çengel Kültür SE; Demirkan K
    Int J Clin Pract; 2021 Jun; 75(6):e14107. PubMed ID: 33624394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
    Khan Q; Ismail M; Haider I; Khan F
    Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.
    Wang H; Shi H; Wang N; Wang Y; Zhang L; Zhao Y; Xie J
    BMC Pharmacol Toxicol; 2022 Jun; 23(1):39. PubMed ID: 35701808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.